Genentech submits sBLA for Lucentis for diabetic retinopathy

The Genentech Inc. unit of Roche (SIX:ROG; OTCQX:RHHBY) submitted an sBLA to FDA to expand the label for Lucentis ranibizumab to include diabetic retinopathy. The humanized mAb fragment against VEGF-A...